ARCHIVES

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Northwestern To Test Method To Detect Colon Cancer

February 25, 2005

Henschke and Supporters Call For Urgent Action Based On Results Of NLST

May 13, 2011

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

September 30, 2011

ASCO Writes A New Mission Statement Placing Emphasis On Helping Patients

May 21, 1999

Trials Could Start Earlier If Model Contract Language Adopted, NCI and CEO Roundtable Say.

December 12, 2008

DCT Board Approves New Imaging Study In Split Vote, Small Grant Program

October 27, 1989